1) Liu B, Zhang M, Chu H, Zhang H, Wu H, Song G, Wang P, Zhao K, Hou J, Wang X, Zhang L, Gao Chengjiang*. The ubiquitin E3 ligase TRIM31 promotes aggregation and activation of the signaling adaptor MAVS through Lys63-linked polyubiquitination. Nat Immunol. 2017, 18(2):214-224.

2) Song H, Liu B, Huai W, Yu Z, Wang W, Zhao J, Han L, Jiang G, Zhang L, Gao Chengjiang*, Zhao Wei*. The E3 ubiquitin ligase TRIM31 attenuates NLRP3 inflammasome activation by promoting proteasomal degradation of NLRP3. Nat Commun. 2016, 7:13727.

3) Song G, Liu B, Li Z, Wu H, Wang P, Zhao K, Jiang G, Zhang L, Gao Chengjiang*. E3 ubiquitin ligase RNF128 promotes innate antiviral immunity through K63-linked ubiquitination of TBK1. Nat Immunol. 2016, 17(12):1342-1351.

4) Zhao K, Zhang M, Zhang L, Wang P, Song G, Liu B, Wu H, Yin Z, Gao Chengjiang*. 2016. Intracellular osteopontin stabilizes TRAF3 to positively regulate innate antiviral response. Sci. Rep. 6:23771.

5) Wang P, Zhao W, Zhao K, Zhang L, Gao chengjiang*.  TRIM26 negatively regulates interferon-β production and antiviral response through polyubiquitination and degradation of nuclear IRF3. Plos Pathog. 2015.11(3):e1004726.

6) Zhang L, Zhao X, Zhang M, Zhao W, Gao Chengjiang*.Ubiquitin-specific protease 2b negatively regulates IFN-β production and antiviral activity by targeting TANK-binding kinase 1. J. Immunol. 2014. 193(5):2230-2237.

7) Wang L. Zhang L, Zhao X, Zhang M, Zhao Wei*, Gao Chengjiang*. Lithium attenuates IFN-β production and antiviral response via inhibition of TANK-binding kinase 1 kinase activity. J. Immunol. 2013. 191(8), 4392-4398.

8) Wang L, Zhao W, Zhang M, Wang P, Zhao K, Zhao X, Yang S, Gao Chengjiang*. 2013. USP4 positively regulates RIG-I-mediated antiviral response through deubiquitination and stabilization of RIG-I. J. Virol. 87(8):4507-4515.

9) Lian K, Ma C, Hao C, Li Y, Zhang N, Chen YH, and Liu S*. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-kB signaling pathways. Oncotarget, 2017 Jul 25;8(30):48889-48904. doi: 10.18632/oncotarget.16522.

10) Hao C, Zhang N, Geng M, Ren Q, Li Y, Wang Y, Chen YH., and Liu S*. Clinical Significance of TIPE2 Protein Upregulation in Non-Hodgkin’s Lymphoma. J Histochem Cytochem. 2016; 64(9):556-564